{"id":907018,"date":"2025-11-06T16:07:09","date_gmt":"2025-11-06T21:07:09","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-third-quarter-financial-results-and-provide-business-update-on-november-12-2025\/"},"modified":"2025-11-06T16:07:09","modified_gmt":"2025-11-06T21:07:09","slug":"humacyte-to-present-third-quarter-financial-results-and-provide-business-update-on-november-12-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-third-quarter-financial-results-and-provide-business-update-on-november-12-2025\/","title":{"rendered":"Humacyte to Present Third Quarter Financial Results and Provide Business Update on November 12, 2025"},"content":{"rendered":"
\n

DURHAM, N.C., Nov. 06, 2025 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, will release its financial results for the quarter ended September 30, 2025, on Wednesday, November 12, 2025. Management will host a webcast and conference call at 8:00 a.m. ET to provide a corporate and financial update.<\/p>\n\n\n\n\n\n\n\n
\n Title:<\/strong>\n <\/td>\nHumacyte Third Quarter 2025 Financial Results and Corporate Update<\/td>\n<\/tr>\n
\n Date:<\/strong>\n <\/td>\nNovember 12, 2025<\/td>\n<\/tr>\n
\n Time:<\/strong>\n <\/td>\n8:00 AM Eastern Time<\/td>\n<\/tr>\n
\n Conference Call Details:<\/strong>\n <\/td>\n1-877-704-4453 (U.S. Investors Dial)
1-201-389-0920 (International Investors Dial)
13756236 (Conference ID)<\/td>\n<\/tr>\n
\n Call me<\/strong>
\n \u2122<\/strong>
\n Feature: <\/strong>\n <\/td>\n		\n Click Here<\/a>\n <\/td>\n<\/tr>\n
\n Webcast:<\/strong>\n <\/td>\n\n Click Here<\/a>\n <\/td>\n<\/tr>\n<\/table>\n

The webcast should be accessible 15 minutes prior to the conference call\u2019s start time. A replay of the webcast will be available following the conclusion of the live broadcast and will be accessible on the investors section of the Company\u2019s website for at least 30 days.<\/p>\n

\n About Humacyte<\/strong>\n <\/p>\n

Humacyte, Inc. (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues, advanced tissue constructs, and organ systems designed to improve the lives of patients and transform the practice of medicine. The Company develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Biologics License Application for the acellular tissue engineered vessel (ATEV) in the vascular trauma indication was approved by the FDA in December 2024. ATEVs are also currently in late-stage clinical trials targeting other vascular applications, including arteriovenous (AV) access for hemodialysis and peripheral artery disease. Preclinical development is also underway in coronary artery bypass grafts, pediatric heart surgery, treatment of type 1 diabetes, and multiple novel cell and tissue applications. Humacyte\u2019s 6mm ATEV for AV access in hemodialysis was the first product candidate to receive the FDA\u2019s Regenerative Medicine Advanced Therapy (RMAT) designation and has also received FDA Fast Track designation. Humacyte\u2019s 6mm ATEV for urgent arterial repair following extremity vascular trauma and for advanced PAD also have received an RMAT designations. The ATEV received priority designation for the treatment of vascular trauma by the U.S. Secretary of Defense. For more information, visit www.Humacyte.com.<\/p>\n

For uses other than the FDA approval in the extremity vascular trauma indication, the ATEV is an investigational product and has not been approved for sale by the FDA or any other regulatory agency.<\/p>\n

\n Humacyte Investor Contact:<\/strong>
\n
Joyce Allaire
LifeSci Advisors LLC
+1-617-435-6602
jallaire@lifesciadvisors.com<\/u><\/a>
<\/a>investors@humacyte.com<\/u><\/a><\/p>\n

\n Humacyte Media Contact:<\/strong>
\n
Rich Luchette
Precision Strategies
+1-202-845-3924
rich@precisionstrategies.com<\/u><\/a>
<\/a>media@humacyte.com<\/u><\/a><\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

DURHAM, N.C., Nov. 06, 2025 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, will release its financial results for the quarter ended September 30, 2025, on Wednesday, November 12, 2025. Management will host a webcast and conference call at 8:00 a.m. ET to provide a corporate and financial update. Title: Humacyte Third Quarter 2025 Financial Results and Corporate Update Date: November 12, 2025 Time: 8:00 AM Eastern Time Conference Call Details: 1-877-704-4453 (U.S. Investors Dial)1-201-389-0920 (International Investors Dial)13756236 (Conference ID) Call me \u2122 Feature: Click Here Webcast: Click Here The webcast should be accessible 15 minutes prior to the conference call\u2019s start time. A replay of the … <\/p>\n

Continue reading “Humacyte to Present Third Quarter Financial Results and Provide Business Update on November 12, 2025”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-907018","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nHumacyte to Present Third Quarter Financial Results and Provide Business Update on November 12, 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-third-quarter-financial-results-and-provide-business-update-on-november-12-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Humacyte to Present Third Quarter Financial Results and Provide Business Update on November 12, 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"DURHAM, N.C., Nov. 06, 2025 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, will release its financial results for the quarter ended September 30, 2025, on Wednesday, November 12, 2025. Management will host a webcast and conference call at 8:00 a.m. ET to provide a corporate and financial update. Title: Humacyte Third Quarter 2025 Financial Results and Corporate Update Date: November 12, 2025 Time: 8:00 AM Eastern Time Conference Call Details: 1-877-704-4453 (U.S. Investors Dial)1-201-389-0920 (International Investors Dial)13756236 (Conference ID) Call me \u2122 Feature: Click Here Webcast: Click Here The webcast should be accessible 15 minutes prior to the conference call\u2019s start time. A replay of the … Continue reading "Humacyte to Present Third Quarter Financial Results and Provide Business Update on November 12, 2025"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-third-quarter-financial-results-and-provide-business-update-on-november-12-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-06T21:07:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2OTg4MCM3MjQ2ODE1IzIyMDk0MzY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-to-present-third-quarter-financial-results-and-provide-business-update-on-november-12-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-to-present-third-quarter-financial-results-and-provide-business-update-on-november-12-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Humacyte to Present Third Quarter Financial Results and Provide Business Update on November 12, 2025\",\"datePublished\":\"2025-11-06T21:07:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-to-present-third-quarter-financial-results-and-provide-business-update-on-november-12-2025\\\/\"},\"wordCount\":426,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-to-present-third-quarter-financial-results-and-provide-business-update-on-november-12-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2OTg4MCM3MjQ2ODE1IzIyMDk0MzY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-to-present-third-quarter-financial-results-and-provide-business-update-on-november-12-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-to-present-third-quarter-financial-results-and-provide-business-update-on-november-12-2025\\\/\",\"name\":\"Humacyte to Present Third Quarter Financial Results and Provide Business Update on November 12, 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-to-present-third-quarter-financial-results-and-provide-business-update-on-november-12-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-to-present-third-quarter-financial-results-and-provide-business-update-on-november-12-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2OTg4MCM3MjQ2ODE1IzIyMDk0MzY=\",\"datePublished\":\"2025-11-06T21:07:09+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-to-present-third-quarter-financial-results-and-provide-business-update-on-november-12-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-to-present-third-quarter-financial-results-and-provide-business-update-on-november-12-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-to-present-third-quarter-financial-results-and-provide-business-update-on-november-12-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2OTg4MCM3MjQ2ODE1IzIyMDk0MzY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2OTg4MCM3MjQ2ODE1IzIyMDk0MzY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-to-present-third-quarter-financial-results-and-provide-business-update-on-november-12-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Humacyte to Present Third Quarter Financial Results and Provide Business Update on November 12, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Humacyte to Present Third Quarter Financial Results and Provide Business Update on November 12, 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-third-quarter-financial-results-and-provide-business-update-on-november-12-2025\/","og_locale":"en_US","og_type":"article","og_title":"Humacyte to Present Third Quarter Financial Results and Provide Business Update on November 12, 2025 - Market Newsdesk","og_description":"DURHAM, N.C., Nov. 06, 2025 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, will release its financial results for the quarter ended September 30, 2025, on Wednesday, November 12, 2025. Management will host a webcast and conference call at 8:00 a.m. ET to provide a corporate and financial update. Title: Humacyte Third Quarter 2025 Financial Results and Corporate Update Date: November 12, 2025 Time: 8:00 AM Eastern Time Conference Call Details: 1-877-704-4453 (U.S. Investors Dial)1-201-389-0920 (International Investors Dial)13756236 (Conference ID) Call me \u2122 Feature: Click Here Webcast: Click Here The webcast should be accessible 15 minutes prior to the conference call\u2019s start time. A replay of the … Continue reading \"Humacyte to Present Third Quarter Financial Results and Provide Business Update on November 12, 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-third-quarter-financial-results-and-provide-business-update-on-november-12-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-11-06T21:07:09+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2OTg4MCM3MjQ2ODE1IzIyMDk0MzY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-third-quarter-financial-results-and-provide-business-update-on-november-12-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-third-quarter-financial-results-and-provide-business-update-on-november-12-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Humacyte to Present Third Quarter Financial Results and Provide Business Update on November 12, 2025","datePublished":"2025-11-06T21:07:09+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-third-quarter-financial-results-and-provide-business-update-on-november-12-2025\/"},"wordCount":426,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-third-quarter-financial-results-and-provide-business-update-on-november-12-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2OTg4MCM3MjQ2ODE1IzIyMDk0MzY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-third-quarter-financial-results-and-provide-business-update-on-november-12-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-third-quarter-financial-results-and-provide-business-update-on-november-12-2025\/","name":"Humacyte to Present Third Quarter Financial Results and Provide Business Update on November 12, 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-third-quarter-financial-results-and-provide-business-update-on-november-12-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-third-quarter-financial-results-and-provide-business-update-on-november-12-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2OTg4MCM3MjQ2ODE1IzIyMDk0MzY=","datePublished":"2025-11-06T21:07:09+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-third-quarter-financial-results-and-provide-business-update-on-november-12-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-third-quarter-financial-results-and-provide-business-update-on-november-12-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-third-quarter-financial-results-and-provide-business-update-on-november-12-2025\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2OTg4MCM3MjQ2ODE1IzIyMDk0MzY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2OTg4MCM3MjQ2ODE1IzIyMDk0MzY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-third-quarter-financial-results-and-provide-business-update-on-november-12-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Humacyte to Present Third Quarter Financial Results and Provide Business Update on November 12, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/907018","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=907018"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/907018\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=907018"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=907018"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=907018"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}